Skip to main content

Share story

Science Infrastructure

nT-Tao says it deployed 50 MW pulsed-power subsystem for fusion prototype

nT-Tao says it deployed 50 MW pulsed-power subsystem for fusion prototype Image: Primary
nT-Tao said it developed and deployed a 50 MW pulsed-power subsystem for its C3 fusion-prototype series. The company said the system combines 50 roughly 1 MW power-electronic generators with real-time nonlinear control and is intended to move the prototype toward its next temperature milestone. It described the subsystem as a roughly fivefold scale-up from an earlier 12-generator, approximately 10 MW system. The company said its prototype had previously demonstrated 1.5 million degrees Celsius.
Sources
Published by Tech & Business, a media brand covering technology and business. This story was sourced from Markets Insider and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Infrastructure Science
Infrastructure Science

Quilty Space projects shortfall of about 150 launches through 2030

The world outside China faces a shortfall of about 150 rocket launches through 2030 against demand from satellite operators and civil space agencies, analytics firm Quilty Space estimates in a new report.

Science Infrastructure
Science Infrastructure

CloudFront adds headers for viewer networks and post-quantum connections

Amazon says CloudFront can now forward optional headers that identify a viewer's internet service provider and describe the cryptography used on the viewer's connection. Website operators can use them to analyze traffic by network and measure use of post-quantum cryptography.

AI Infrastructure
AI Infrastructure

Five technology giants commit more than $3T to future spending

Alphabet, Meta, Microsoft, Amazon and Oracle have committed more than $3T to future spending on data centres, leases, equipment and energy, The Next Web reported, citing Bloomberg. Alphabet accounts for more than $1T and Meta for more than $800B.

AI Science
AI Science

Insilico says AI-discovered Rentosertib has entered Phase III trials

Insilico Medicine says Rentosertib, its generative AI-discovered drug candidate also known as ISM001-055, has entered Phase III clinical trials for idiopathic pulmonary fibrosis. The company described the clinical advance in an announcement carried by News-Medical.Net.